C96.20

Billable

Malignant mast cell neoplasm, unspecified

HCC Category Mapping

V28HCC 21 — Breast, Prostate, Colorectal and Other Cancers and Tumors

0.545

V24HCC 10 — Lymphoma and Other Cancers

0.675

ESRDHCC 10 — Lymphoma and Other Cancers

0.000

RxHCCHCC 21 — Hodgkin Lymphoma and Other Cancers

0.000

What This Code Means

A malignant cancer arising from mast cells (immune cells) where the specific type or extent of disease is not specified.

Coding Tips

•Use this code only when the specific type of mast cell neoplasm cannot be determined from documentation
•Review records for more specific information to assign C96.21, C96.22, or C96.29 if available

Clinical Significance

Malignant mast cell neoplasm, unspecified, is used when a mast cell malignancy is confirmed but the specific subtype (aggressive systemic mastocytosis, mast cell sarcoma, or mast cell leukemia) cannot be determined from available documentation. Mast cell malignancies require specialized evaluation to guide treatment selection.

Documentation Requirements

✓Documentation should confirm the malignant nature of the mast cell proliferation and explain why further subclassification is not possible.
✓Bone marrow biopsy findings, serum tryptase levels, KIT mutation status, and the presence or absence of organ damage should be recorded to enable more specific classification.

Commonly Confused Codes

C96.21 (aggressive systemic mastocytosis), C96.22 (mast cell sarcoma), and C94.3 (mast cell leukemia) are more specific alternatives. D47.02 (systemic mastocytosis) is for non-aggressive forms. C96.29 (other malignant mast cell neoplasm) is used for known but non-standard malignant variants.

Code Hierarchy

└C96Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue └C96.2Malignant mast cell neoplasm └C96.20Malignant mast cell neoplasm, unspecified

└C96.20Malignant mast cell neoplasm, unspecified